Tatva Chintan Pharma Chem (NSE:TATVA) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 30, 2026)


NSE:TATVA Tatva Chintan Pharma Chem Ltd NSE:TATVA
81 GF Score
Price ₹1,196.00
GF Value ₹1,453.22
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Tatva Chintan Pharma Chem's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

NSE:TATVA vs LIN, SHW, ECL: Margin of Safety % (DCF Earnings Based) Comparison

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tatva Chintan Pharma Chem Margin of Safety % (DCF Earnings Based) vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's Margin of Safety % (DCF Earnings Based) falls into.


NSE:TATVA
81GF Score
Tatva Chintan Pharma Chem Ltd NSE:TATVA
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be undervalued. The current stock price of ₹1,196.00 is trading 17.7% below its estimated GF Value™ of ₹1,453.22. GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Undervalued.

Key valuation signals for NSE:TATVA:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹1,453.22 vs. price of ₹1,196.00 (17.7% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tatva Chintan Pharma Chem Business Description

Other Exchanges 543321:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
81GF Score

Get the complete analysis for NSE:TATVA

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,196.00
Price
₹1,453.22
GF Value